Back to results
US 2023/0408521 A1Published application
Gdf-15 as a diagnostic marker for melanoma
AssigneeJulius-Maximilians-UniversitäT WüRzburg
InventorsJörg WISCHHUSEN, Tina SCHÄFER, Benjamin WEIDE
Life of this patent
Estimating the term…
Abstract
The present invention relates to methods for predicting the probability of survival of a human melanoma cancer patient based on levels of human GDF-15, and to apparatuses and kits which can be used in these methods.
Claims21
1-37. (canceled)
A method for treating melanoma in a patient in need thereof, the method comprising the steps of:
- (a) determining the level of hGDF-15 in a blood sample obtained from a patient who is receiving or has received treatment for melanoma;
- and
- (b) if the level of hGDF-15 in the blood sample is more than 1.1 ng/ml, administering an adjuvant therapy to the patient and/or placing the patient under an intensified surveillance protocol.
A method for treating melanoma in a patent in need thereof, the method comprising the steps of:
- (a) selecting a patient that is receiving or has received treatment for melanoma and has a blood level of hGDF-15 that is more than 1.1 ng/ml;
- and
- (b) administering an adjuvant therapy to the patient and/or placing the patient under an intensified surveillance protocol.
Dependencies are inferred from the claim text.